뇌경색 위험인자로서의 혈중 지질에 대한 임상적 연구 = A Clinical Study on Blood Lipids as a Risk Factor of Cerebral Infarction

다국어 초록 (Multilingual Abstract)

Objective The purpose of this case-control study was done to examine the relationship among the acute brain infarction, silent brain infarction and blood lipids. Methods We compared the components of blood lipids among acute brain infarction patients group (n=99), silent brain infarction patients group(n=101) and controls group (n=153). The analysis of the data was done by Frequency Analysis, one-way ANOVA, Post Hoc Test(Duncan), Pearson's Correlation. Results The results were as follows. High density lipoprotein cholesterol(HDL-Chol) was significantly lower in patients of acute brain infarctions group. The blood levels of total cholesterol(T-Chol) was significantly higher in patients of silent brain infarctions. A study on the relationship among the significant variables ; In T-Chol and HDL-Chol, DM(No=0, Yes=1) and Age, they had positive correlation each other. Between Sex(Female=0, Male=1) and HDL-Chol, Age and HDL-Chol, DM and HDL-Chol, they had negative correlation each other. Conclusions These results suggest that low HDL-Chol may be risk factor of acute brain infarction.

참고문헌 (Reference)

1 탁양주, "혈청 총콜레스테롤과 관련된 인자들" 13 (13): 935-942, 1992

2 이선우, "중풍 환자의 사상체질 유형별 혈중지질 분포에 대한 상관성 연구" 대한한방내과학회 27 (27): 488-499, 2006

3 박영배, "정상인 및 각종질환에서의 혈청지질에 관한 연구: HDL Cholesterol을 중심으로" 11 (11): 55-68, 1981

4 김영석, "임상중풍학" 서원당 1997

5 경희의료원 한방병원 제2내과학교실, "오늘의 한방중풍치료" 서원당 15-20, 2004

6 이원로, "심장학. 제1판" 고려의학 748-, 1998

7 백혜기, "무증상 뇌경색의 위험요인에 대한 환자 - 대조군 연구" 대한한방내과학회 28 (28): 850-862, 2007

8 위봉애, "뇌혈전증 환자에서의 혈청지질에 대한 조사" 7 (7): 258-265, 1989

9 이현의, "뇌졸중의 위험지표로서의 일반혈액검사 소견에 대한 환자-대조군 연구" 28 (28): 872-885, 2007

10 신건민, "뇌졸중의 위험인자에 관한 조사" 6 (6): 218-227, 1988

11 부송아, "뇌졸중의 위험요인에 대한 환자-대조군 연구-과거병력, 생활습관, 혈청지질 및 비만 요인을 중심으로-" 22 (22): 423-430, 2001

12 조길우, "뇌경색증과 심근경색환자에서 죽상동맥경화 위험요인의 비교 연구" 41 (41): 469-480, 1991

13 방혜정, "고지혈증에 대한 한의학적 고찰" 20 (20): 25-36, 1985

14 Prospective studies collaboration, "cholesterol, diastolic blood pressure, and stroke; 13,000 strokes in 450,000 people in 45 prospective cohorts" 346 : 1647-1653, 1995

15 Chodosh EH., "Silent stroke in the NINCDS Stroke Data Bank" 38 : 1674-1679, 1988

16 Herderschee D., "Silent stroke in patients with transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group" 23 (23): 1220-1224, 1992

17 Yoon SK., "Silent brain infarcts in first-ever ischemic stroke pations; MRI findings and stroke risk factors" 14 : 42-45, 1996

18 Caplan LR., "Silent brain infarcts" 4 : 32-39, 1994

19 Rhoads GA., "Serum triglyceride and risk of coronary heart disease, stroke and total mortality in Japanese-American men" 3 : 316-322, 1983

20 Ivar M., "Serum lipids after stroke" 37 : 501-511, 1987

21 American Diabetes Association, "Report of the expert committee on the Diagnosis and clsssification of Diabetes Mellitus" 20 : 1183-1197, 1997

22 Brown G., "Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B" 323 (323): 1289-1298, 1990

23 Isselbacher KJ., "Principle of internal medicine. Harrison. 13thed" McGraw Hill 1106-1116, 1994

24 Kase CS., "Prevalence of silent stroke in pationts presenting with intial stroke: The Framingham Study" 20 : 850-852, 1989

25 Vermeer SE., "Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study" 33 : 21-25, 2002

26 Miller GJ., "Plasma-high-density lipoprotein concentration and development of ischemic heart disease" 1 : 16-19, 1975

27 Shahar E., "Plasma lipid profile and incident ischemic stroke" 34 (34): 623-631, 2003

28 Choi-Kwon S., "Nutritional status in acute stroke; undernutrition versus overnutrition in different stroke subtypes" 98 : 187-192, 1998

29 "NHANES(National Health and Nutrition Examination Survey) Ⅲ"

30 Whisnant JP., "Modelling of risk factors for ischemic stroke" 28 : 1840-1844, 1997

31 Gordon T., "Lipoprotein; cardiovascular disease and death: The Framingham Study" 141 : 1128-1135, 1981

32 Juan PB., "Lipoprotein and apolipoprotein profile in men with ischemic stroke" 23 (23): 1556-1562, 1992

33 Anual report on the cause of death statistics, "Korean National Statistical Office"

34 WHO Western Pacific Region, "International Association for the Study of Obesty, International Obesty Task Force. The Asia-Pacific perspective; redefining obesty and its treatment" Health Communications 2000

35 Lindenstrom L., "Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerdes on risk of cerebrovascular disease: The Copenhagen City Heart" 309 : 11-15, 1994

36 Amarenco P., "Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction" 57 (57): 35-44, 2001

37 Iso H., "Cohen JD for the MRFIT Research Group. Serum cholesterol levels and six-year mortality from stroke in 35,977 men screened for the multiple risk factor intervention trial" 320 : 904-910, 1989

38 Van Hinsbergh VW., "Arteriosclerosis. impairment of cellular interactions in the arterial wall" 673 : 321-330, 1992

39 Woo J., "Acute and long-term changes in serum lipids after acute stroke" 21 : 1407-1411, 1990

40 한기훈, "2002 내과학의 최신지견Ⅴ(고지혈증의 진단 및 치료에 대한 접근)" 울산의대 서울아산병원 내과 125-137, 2002